Song J, Zhou T, Luo Y, Liu Y
World J Gastrointest Surg. 2025; 17(2):101239.
PMID: 40061976
PMC: 11886007.
DOI: 10.4240/wjgs.v17.i2.101239.
Shin H, Takatsu H
Commun Biol. 2025; 8(1):135.
PMID: 39875509
PMC: 11775268.
DOI: 10.1038/s42003-025-07549-3.
Hayes C, Gallucci G, Boyer J, Assis D, Ghonem N
Hepatol Commun. 2024; 9(1).
PMID: 39699308
PMC: 11661771.
DOI: 10.1097/HC9.0000000000000612.
Percheron A, Guerry P, Fabre A
Intractable Rare Dis Res. 2024; 13(4):255-258.
PMID: 39628627
PMC: 11609038.
DOI: 10.5582/irdr.2024.01043.
Riaz H, Zheng B, Zheng Y, Liu Z, Gu H, Imran M
Sci Rep. 2024; 14(1):18876.
PMID: 39143102
PMC: 11324741.
DOI: 10.1038/s41598-024-59945-0.
Iberogast®-Induced Acute Liver Injury-A Case Report.
Leroy A, Perrin H, Porret R, Sempoux C, Chtioui H, Fraga M
Gastro Hep Adv. 2024; 1(4):601-603.
PMID: 39132058
PMC: 11308012.
DOI: 10.1016/j.gastha.2022.02.020.
Consensus, controversies, and conundrums of P4-ATPases: The emerging face of eukaryotic lipid flippases.
Duan H, Li H
J Biol Chem. 2024; 300(6):107387.
PMID: 38763336
PMC: 11225554.
DOI: 10.1016/j.jbc.2024.107387.
Navigating cholestasis: identifying inborn errors of bile acid metabolism for precision diagnosis.
Nittono H, Suzuki M, Suzuki H, Sugimoto S, Mori J, Sakamoto R
Front Pediatr. 2024; 12:1385970.
PMID: 38646510
PMC: 11026588.
DOI: 10.3389/fped.2024.1385970.
Functional and in silico analysis of ATP8A2 and other P4-ATPase variants associated with human genetic diseases.
Matsell E, Andersen J, Molday R
Dis Model Mech. 2024; 17(6).
PMID: 38436085
PMC: 11073571.
DOI: 10.1242/dmm.050546.
The Phospholipid Flippase ATP8B1 is Involved in the Pathogenesis of Ulcerative Colitis via Establishment of Intestinal Barrier Function.
Koelink P, Gomez-Mellado V, Duijst S, van Roest M, Meisner S, Ho-Mok K
J Crohns Colitis. 2024; 18(7):1134-1146.
PMID: 38366839
PMC: 11302967.
DOI: 10.1093/ecco-jcc/jjae024.
Glucosylceramide flippases contribute to cellular glucosylceramide homeostasis.
Kita N, Hamamoto A, Gowda S, Takatsu H, Nakayama K, Arita M
J Lipid Res. 2024; 65(3):100508.
PMID: 38280458
PMC: 10910339.
DOI: 10.1016/j.jlr.2024.100508.
Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis.
Tamura R, Sabu Y, Mizuno T, Mizuno S, Nakano S, Suzuki M
Nat Commun. 2023; 14(1):6763.
PMID: 37990006
PMC: 10663612.
DOI: 10.1038/s41467-023-42424-x.
Activation and substrate specificity of the human P4-ATPase ATP8B1.
Dieudonne T, Kummerer F, Laursen M, Stock C, Flygaard R, Khalid S
Nat Commun. 2023; 14(1):7492.
PMID: 37980352
PMC: 10657443.
DOI: 10.1038/s41467-023-42828-9.
Internal Ileal Diversion as Treatment for Progressive Familial Intrahepatic Cholestasis Type 1-Associated Graft Inflammation and Steatosis after Liver Transplantation.
Kavallar A, Messner F, Scheidl S, Oberhuber R, Schneeberger S, Aldrian D
Children (Basel). 2022; 9(12).
PMID: 36553407
PMC: 9777440.
DOI: 10.3390/children9121964.
ATP8B1 Deficiency Results in Elevated Mitochondrial Phosphatidylethanolamine Levels and Increased Mitochondrial Oxidative Phosphorylation in Human Hepatoma Cells.
Gomez-Mellado V, Chang J, Ho-Mok K, Bernardino Morcillo C, Kersten R, Oude Elferink R
Int J Mol Sci. 2022; 23(20).
PMID: 36293199
PMC: 9604224.
DOI: 10.3390/ijms232012344.
Odevixibat: a promising new treatment for progressive familial intrahepatic cholestasis.
Bedoyan S, Lovell O, Horslen S, Squires J
Expert Opin Pharmacother. 2022; 23(16):1771-1779.
PMID: 36278881
PMC: 10074157.
DOI: 10.1080/14656566.2022.2140040.
Lipid Transport by Dnf2 Is Required for Hyphal Growth and Virulence.
Jain B, Wagner A, Reynolds T, Graham T
Infect Immun. 2022; 90(11):e0041622.
PMID: 36214556
PMC: 9670988.
DOI: 10.1128/iai.00416-22.
The phospholipid flippase ATP8B1 is required for lysosomal fusion in macrophages.
Gomez-Mellado V, Ho-Mok K, van der Mark V, van der Wel N, Grootemaat A, Verhoeven A
Cell Biochem Funct. 2022; 40(8):914-925.
PMID: 36169099
PMC: 10087937.
DOI: 10.1002/cbf.3752.
Genetics in Familial Intrahepatic Cholestasis: Clinical Patterns and Development of Liver and Biliary Cancers: A Review of the Literature.
Vitale G, Mattiaccio A, Conti A, Turco L, Seri M, Piscaglia F
Cancers (Basel). 2022; 14(14).
PMID: 35884482
PMC: 9322180.
DOI: 10.3390/cancers14143421.
Ileal Bile Acid Transporter Inhibition Reduces Post-Transplant Diarrhea and Growth Failure in FIC1 Disease-A Case Report.
Ohlendorf J, Goldschmidt I, Junge N, Laue T, Nasser H, Jackel E
Children (Basel). 2022; 9(5).
PMID: 35626847
PMC: 9139332.
DOI: 10.3390/children9050669.